Author:
Blyth Sophia H.,Zabik Nicole L.,Krosche Amanda,Prisciandaro James J.,Ward Heather Burrell
Funder
National Institute of Mental Health
National Center for Advancing Translational Sciences
Publisher
Springer Science and Business Media LLC
Reference67 articles.
1. Cuffel BJ. Comorbid substance use disorder: prevalence, patterns of use, and course. New Dir Ment Health Serv. 1996;1996(70):93–105.
2. Key substance use and mental health indicators in the United States: results from the 2022 National Survey on Drug Use and Health [Internet]. Center for Behavioral Health Statistics and Quality: Substance Abuse and Mental Health Services Administration; 2023 Nov. (NSDUH Series H-58). Report No.: HHS Publication No. PEP23-07-01-006. Available from: https://www.samhsa.gov/data/report/2022-nsduh-annual-national-report
3. Drake RE, Mueser KT. Psychosocial approaches to dual diagnosis. Schizophr Bull. 2000;26(1):105–18.
4. Drake RE, McLaughlin P, Pepper B, Minkoff K. Dual diagnosis of major mental illness and substance disorder: an overview. New Dir Ment Health Serv. 1991;1991(50):3–12.
5. Harris MG, Bharat C, Glantz MD, Sampson NA, Al-Hamzawi A, Alonso J, et al. Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys. Addiction. 2019;114(8):1446–59.